Verastem (VSTM) Enterprise Value (2011 - 2026)
Verastem (VSTM) recorded quarterly Enterprise Value of -$181.7 million in Q1 2026, up 11.37% quarter-over-quarter from -$205.0 million in Q4 2025, and down 54.53% on a YoY basis from -$399.5 million in Q1 2025.
Verastem (VSTM) Enterprise Value (2011 - 2026) Analysis & Trends
Verastem's Enterprise Value history runs 16 years deep, the most recent figure standing at -$181.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 54.53% year-over-year to -$181.7 million; the TTM figure through Mar 2026 stood at -$181.7 million (down 54.53% YoY), while the FY2025 annual figure was -$205.0 million, down 130.8% from the prior year.
- Enterprise Value was -$181.7 million for Q1 2026 at Verastem, up from -$205.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$83.4 million in Q2 2024 to a low of -$205.0 million in Q4 2025.
- Historically, Enterprise Value has averaged -$129.1 million across 5 years, with a median of -$113.2 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value soared 54.46% in 2024, then plunged 130.8% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$92.0 million in 2022, then tumbled by 48.99% to -$137.1 million in 2023, then jumped by 35.23% to -$88.8 million in 2024, then sank by 130.8% to -$205.0 million in 2025, then rose by 11.37% to -$181.7 million in 2026.
- The last three Enterprise Value figures came in at -$181.7 million (Q1 2026), -$205.0 million (Q4 2025), and -$137.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -181.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -181.68 Mn |
| Dec 31, 2025 | -204.99 Mn |
| Sep 30, 2025 | -137.71 Mn |
| Jun 30, 2025 | -164.32 Mn |
| Mar 31, 2025 | -117.57 Mn |
| Dec 31, 2024 | -88.82 Mn |
| Sep 30, 2024 | -113.18 Mn |
| Jun 30, 2024 | -83.37 Mn |
| Mar 31, 2024 | -110.13 Mn |
| Dec 31, 2023 | -137.13 Mn |
| Sep 30, 2023 | -165.66 Mn |
| Jun 30, 2023 | -183.09 Mn |
| Mar 31, 2023 | -111.20 Mn |
| Dec 31, 2022 | -92.04 Mn |
| Sep 30, 2022 | -103.98 Mn |
| Jun 30, 2022 | -94.31 Mn |
| Mar 31, 2022 | -106.28 Mn |
| Dec 31, 2021 | -153.80 Mn |
| Sep 30, 2021 | -103.42 Mn |
| Jun 30, 2021 | -108.14 Mn |